Biomerica (BMRA) Other Non Operating Income (2010 - 2026)

Biomerica (BMRA) reported Other Non Operating Income of -$6000.0 for Q1 2026, down 113.95% on a YoY basis from $43000.0 in Q1 2025, and up 97.21% sequentially from -$215000.0 in Q2 2025.

Biomerica (BMRA) Other Non Operating Income (2010 - 2026) Analysis & Trends

Biomerica (BMRA) has 6 years of Other Non Operating Income data on file, last reported at -$6000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non Operating Income fell 113.95% year-over-year to -$6000.0; the trailing twelve-month figure through Feb 2026 stood at -$173014.0 (down 407.9% YoY), and the FY2025 full-year result was -$75000.0, up 56.4% from the prior year.
  • Other Non Operating Income improved to -$6000.0 in Q1 2026, from -$215000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $43000.0 in Q1 2025 to a low of -$215000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Biomerica 4.85 Mn 3.51 Mn -44,000.00

Historic Data

Download Data
DateValue
Feb 28, 2026 -6,000.00
May 31, 2025 -215,000.00
Feb 28, 2025 43,000.00
May 31, 2013 4,986.00
Feb 28, 2013 7,079.00
Nov 30, 2012 1,127.00
Aug 31, 2012 808.00
May 31, 2012 27,265.00
Feb 29, 2012 72,526.00
Nov 30, 2011 1,006.00
Aug 31, 2011 891.00
May 31, 2011 113,523.00
Feb 28, 2011 388.00
Nov 30, 2010 177,752.00